Progenics Investors Seek Changes at the Top as Activist Gains Traction

(Bloomberg) -- Progenics Pharmaceuticals Inc.’s disappointing performance has driven some investors to side with activist shareholder Velan Capital LP as they push for significant changes.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.